| Literature DB >> 31992987 |
Érica Cerqueira1, Daniel A Marinho2,3, Henrique P Neiva2,3, Olga Lourenço1,4.
Abstract
Background: Exercise leads to a robust inflammatory response mainly characterized by the mobilization of leukocytes and an increase in circulating inflammatory mediators produced by immune cells and directly from the active muscle tissue. Both positive and negative effects on immune function and susceptibility to minor illness have been observed following different training protocols. While engaging in moderate activity may enhance immune function above sedentary levels, excessive amounts of prolonged, high-intensity exercise may impair immune function. Thus, the aim of the present review was to clarify the inflammatory effects in response to different exercise intensities.Entities:
Keywords: cytokines; exercise; high intensity; inflammation; moderate intensity
Year: 2020 PMID: 31992987 PMCID: PMC6962351 DOI: 10.3389/fphys.2019.01550
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Search strategy and inclusion/exclusion criteria based on PICO.
| PubMed | Inflammation | Population | Healthy adults | Sedentary adults; adults with disease |
| Intervention | Moderate exercise | No exercise intensity definition | ||
| Intense exercise | ||||
| Comparison | Intense with moderate exercise | |||
| Outcome | Alterations in PBMC (WBC, lymphocytes, NK cells, or NK cytolytic activity), Cytokines (IL-6, IL-8, IL-1β, TNF-α, or IL-10), CRP, or CK | No results on inflammatory markers |
Figure 1PRISMA (preferred reporting items for systematic reviews and meta-analyses) study flow diagram.
Studies characteristics.
| Gonzalo-Calvo et al. ( | Cross-sectional | Intense: 10 km-race (89.12% VO2max) | 9 M | PBMC: WBC, lymphocytes | 1.5 h before exer, 10 min, 1 day and 3 days after | ↑WBC, Lymphocytes and NK cells 10 min after exer |
| Intense: HM (81.50% VO2max) | CRP | ↑WBC, NK cells, IL-6, IL-10 and CRP 10 min after exer | ||||
| Intense: Marathon (68.70% VO2max) | ↑WBC, NK cells, IL-6, IL-8, IL-10 and CRP 10 min after exer | |||||
| Wadley et al. ( | Cross-sectional | Intense: LV-HIIE (90% VO2max) and high (80% VO2max) | 10 M | PBMC: Lymphocytes | Before, at the end and 30 min after exer | ↑Lymphocytes at the end, returns to baseline in 30 min |
| Moderate: cycled for 27 min(60% VO2max) | ↑Lymphocytes at the end and returns to baseline in 30 min | |||||
| Ulven et al. ( | Cross-sectional | Intense: Cycled for 1 h repeated twice | 10 M | Cytokines: IL-6, IL-10, and TNF-α | Before and at the end of cycle test | ↑IL-6, IL-10, and TNF-α at the end of exer |
| Azizbeigi et al. ( | Controlled Trial | Intense: Resistance training (85–90% of 1 RM) | 30 M | Cytokines: IL-6 and TNF-α | Before, at the end and 3 days after training program | ↔IL-6, TNF-α, and CK |
| Stelzer et al. ( | Cross-sectional | Intense: Cycling race (98.68% HRmax) | 7 (3 F: 4 M) | PBMC: WBC and lymphocytes | 2 days pre-race and 15 min post-race | ↑WBC, lymphocytes, IL-6, and CK post-race |
| Abbasi et al. ( | Cross-sectional | Intense: HM in competition conditions | 16 (8 F: 8 M) | PBMC: WBC and lymphocytes; | Before, 30 min, | ↑WBC at 30 min and 3 h after exer↓Lymphocytes at 30 min and 3 h after exer |
| Draganidis et al. ( | Cross-sectional | Intense: Resistance training: squat, seated leg extension, horizontal leg curls, barbell side lunges, and calf raises; (85–90% 1 RM) | 10 M | PBMC: WBC | After, at the end, and daily for 3 days after the exer | ↑CRP at the end to 1 day and after returns to baseline |
| Moderate: Resistance training: squat, seated leg extension, horizontal leg curls, barbell side lunges, and calf raises | ↑WBC and CRP at 1 day and after returns to baseline | |||||
| Marklund et al. ( | Cross-sectional | Moderate: 24 h ultra-endurance exer: running, cycling, and kayaking | 9 M | PBMC: WBC | Before, at the end and 28 h after the exer | ↑WBC, IL-6 and CK at the end and ↓28 h after exerc |
| Nieman et al. ( | Cross-sectional | Intense: 1.75 h cycling followed by 10 km time trial as fast as possible (18.3 ± 1.7 min) total of 2.1 h cycling (Borg scale = 13.3 ± 1.1 and 82.2 ± 6.1% HR max) | 31 M | PBMC: WBC and lymphocytes | Before, at the end and 1 h post-exer | ↑WBC and lymphocyte at the end and ↓1 h after exer |
| Bernecker et al. ( | Cross-sectional | Intense: Marathon | 12 M | PBMC: WBC | Before and 1 h after exer | ↑WBC, IL-6, and TNF-α 1 h after exer |
| Spiropoulos et al. ( | Cross-sectional | Intense: Ultra-endurance foot race over a distance of 246 km (9.08 MET by middle age) | 10 M | PBMC: WBC | Before, at the end and 2 days after race | ↑WBC, IL-6 and CRP at the end of exer, IL-6 and WBC return to baseline 2 days after but CRP still ↑ |
| Fatouros et al. ( | Cross-sectional | Intense: 4 × 3 wk resistance training period divided in t1, t2, t3, and t4 | 17 M | CRP | Before and 96 h after each session of exer | ↑CRP after t2 and t3 |
| Degerstrøm and Østerud ( | Cross-sectional | Intense: 2 sets of 30 min run with 4 h rest | 7 M | PBMC: WBC and lymphocytes | Before, at the end each run and 2 h after second run | WBC: |
| Connolly et al. ( | Controlled Trial | Intense: 30 min cycling (80% VO2max) | PBMC: WBC and lymphocytes | Before, at the end and 1 h after exer | ↑WBC and lymphocytes at the end of exer and return to baseline | |
| Bonsignore et al. ( | Cross-sectional | Intense: Marathon | 8 M | PBMC: WBC and lymphocytes | After and at the end of exer | ↑WBC at the end of exer↓Lymphocytes at the end of exer |
| Mucci et al. ( | Controlled Trial | Intense: | 22 M | Cytokines: IL-1β and IL-8 | Before the exer, at 50% VO2max, 75% VO2max, 100% VO2max and recovery (5 min after) | ↑IL-1β both intensities and returns to baseline in recovery↑IL-8 both intensities and returns to baseline in recovery |
| 11 untrained group but physically active (control) | ↑IL-8 at 100% VO2max↔IL-1β | |||||
| Brenner et al. ( | Randomize controlled Trial | Intense: Cycling for 5 min | 8 M | PBMC: NK cells and NK Cytolytic activity | 30 min before, at the end, 3 h, 1 day and 3 days after each test | ↑NK cells at the end of exer and return to baseline 3 h after |
| Upper limit of moderate: 2 h cycling | ↑NK cells at the end of exer and return to baseline 3 h after | |||||
| Moderate: 3 sets of 10 repeats in resistance training (bicep curl, knee extension, hamstring, curl, bench press, and leg press) (60–70% 1 RM) | ||||||
| Ostrowski et al. ( | Cross-sectional | Intense: Marathon (75.33% VO2max) | 10 M | Cytokines: TNF-α, IL-1β, IL-6 and IL-10 | 1 wk before, at the end and every 30 min in the 4 h after exer | ↑TNF-α, IL-1β, IL-6 and IL-10 at the end |
↑, significant increase; ↓, significant decrease; ↔, no change; 1 RM, one repeat maximum; 1st, first; 2nd, second; CK, creatinine kinase; CRP, C-reactive protein; Exer, exercise; F, Female; h, hour; HIGH, high intensity; HM, half marathon; HRmax, maximum heart rate; IL, interleukin; LV-HIIE, high intensity interval exercise; M, male; PBMC, peripheral blood mononuclear cel; TNF-α, Tumor necrosis factor alpha; V, velocity; VO2max, maximum rate of oxygen consumption; WBC, white blood cells; wk, week; yr, years;
<75% in STROBE quality scale;
<75% in CONSORT quality scale.
Immediate effects of moderate and intense exercise (0–15 min) on inflammatory markers.
| WBC | ↔ | Draganidis et al., | ↑] 1.44; 3.5 [x | Bonsignore et al., |
| ↔ | Bernecker et al., | |||
| Lymphocytes | ↑1.41 × | Wadley et al., | ↑] 1.30; 2.69 [x | Connolly et al., |
| ↓4.21 x | Bonsignore et al., | |||
| ↔ | Abbasi et al., | |||
| NK cells | ↑5.5 x | Brenner et al., | ↑8.83 x | Brenner et al., |
| NK cells cytolytic activity | ↑2.92 x | Brenner et al., | ↑4.63 x | Brenner et al., |
| IL-6 | ↑] 1.33; 4.20 [x | Brenner et al., | ↑] 1.59; 26.79 [x | Ostrowski et al., |
| ↔ | Marklund et al., | ↔ | Brenner et al., | |
| IL-10 | ↔ | Brenner et al., | ↑] 1.57; 32.99 [x | Ostrowski et al., |
| ↔ | Brenner et al., | |||
| IL-8 | ↑1.43 x | Mucci et al., | ↑] 1.37; 2.77 [x | Mucci et al., |
| ↔ | Marklund et al., | |||
| IL-1β | ↑1.13 x | Mucci et al., | ↑] 1.13; 1.50 [x | Mucci et al., |
| ↔ | Marklund et al., | |||
| TNF-α | ↔ | Brenner et al., | ↔ | Brenner et al., |
| ↑] 1,30; 2.07 [x | Ostrowski et al., | |||
| CRP | ↑1.23 x | Draganidis et al., | ↑1.4 x | Spiropoulos et al., |
| ↔ | Fatouros et al., | |||
| CK | ↑] 1.92; 24.16 [x | Draganidis et al., | ↑] 2.19; 4.75 [x | Draganidis et al., |
| ↔ | Brenner et al., | ↔ | Brenner et al., |
↑, significant increase; ↓, significant decrease; ↔, no change; CRP, C-reactive protein; d, effect size, expressed as mean ± sd; IL, Interleukin; TNF-α, tumor necrosis factor alpha; WBC, white blood cells;
Spiropoulos et al. was not included to calculate the increase interval of IL-6 and CRP due very discrepant values after exercise when compared to the other studies (1,0470 and 6,000 times, respectively);
Marklund et al. was not included to calculate the increase interval of CRP due baseline value was not detectable.
Gonzalo-Calvo et al. (.